US$ 26.39
glp-1 receptor agonist drugs in development research Market Size GLP-1 Receptor Agonist Market Size
Description
Obesity is a complex disease, excessive fat accumulation caused by genetic, environmental and other factors, that has seen the most rapid growth in terms of ...

Medical-grade dual receptor agonist with expert physician monitoring and personalized weight loss protocols.

Key Mechanisms of Action : GLP-1 Receptor Agonism (Activation): Similar to current weight-loss drugs, it mimics the GLP-1 hormone to increase satiety (feeling full) and reduce appetite

Easy once-a-day use

The World Obesity Atlas 2024 reports over 1.5 billion projected cases by 2035, highlighting its growing threat among pediatric and adult populations globally

Its important to talk with a healthcare provider about how long to use these medicines and make long-term healthy lifestyle changes to help keep weight off for good.What are the side effects?Common side effects include nausea, vomiting, diarrhea, abdominal pain, or constipation
